ATXS vs. CRDF

Last updated Jun 4, 2026

ATXS (Astria Therapeutics, Inc.) and CRDF (Cardiff Oncology, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. At a 0.21 correlation, their price movements are largely independent.

Performance

ATXS vs. CRDF - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Astria Therapeutics, Inc. (ATXS) and Cardiff Oncology, Inc. (CRDF). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

ATXS

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

CRDF

• 1D: -7.28%
• 1M: -15.15%
• YTD: -50.18%
• 6M: -34.27%
• 1Y: -60.11%
• 3Y*: -4.94%
• 5Y*: -28.67%
• 10Y*: -42.80%

*Multi-year figures are annualized to reflect compound growth (CAGR)

ATXS vs. CRDF - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
ATXS Astria Therapeutics, Inc.	-3.90%	46.42%	16.41%	-48.42%	176.25%	-58.02%	-63.79%	35.24%	-70.67%	-58.73%
CRDF Cardiff Oncology, Inc.	-50.18%	-35.25%	193.24%	5.71%	-76.71%	-66.59%	1,350.81%	-60.67%	-85.76%	-85.36%

Correlation

The correlation between ATXS and CRDF is 0.18, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.18
Correlation (3Y) Calculated over the trailing 3-year period	0.18
Correlation (5Y) Calculated over the trailing 5-year period	0.26
Correlation (10Y) Calculated over the trailing 10-year period	0.21
Correlation (All Time) Calculated using the full available price history since Jun 26, 2015	0.21

Fundamentals

Market Cap ATXS : $729.71M CRDF : $95.69M
EPS ATXS : -$2.14 CRDF : -$0.67
PS Ratio ATXS : 1.03K CRDF : 194.23
PB Ratio ATXS : 5.29 CRDF : 2.76
Total Revenue (TTM) ATXS : $706.00K CRDF : $484.00K
Gross Profit (TTM) ATXS : $706.00K CRDF : -$11.32M
EBITDA (TTM) ATXS : -$134.05M CRDF : -$45.29M

Return for Risk

ATXS vs. CRDF — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CRDF

CRDF Risk / Return Rank: 12
CRDF Sharpe Ratio Rank: 12
CRDF Sortino Ratio Rank: 15
CRDF Omega Ratio Rank: 13
CRDF Calmar Ratio Rank: 7
CRDF Martin Ratio Rank: 14

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ATXS vs. CRDF - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Astria Therapeutics, Inc. (ATXS) and Cardiff Oncology, Inc. (CRDF). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	ATXS	CRDF	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	-0.70	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	-0.29	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	-0.41	—
Sharpe Ratio (All Time) Calculated using the full available price history	—	-0.23	—

Drawdowns

Drawdown Indicators

	ATXS	CRDF	Difference
Max Drawdown Largest peak-to-trough decline	—	-99.96%	—
Max Drawdown (1Y) Largest decline over 1 year	—	-68.54%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-76.31%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-88.36%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-99.82%	—
Current Drawdown Current decline from peak	—	-99.93%	—
Average Drawdown Average peak-to-trough decline	—	-86.17%	—
Ulcer Index Depth and duration of drawdowns from previous peaks	—	49.84%	—

Volatility

Volatility by Period

	ATXS	CRDF	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	31.33%	—
Volatility (6M) Calculated over the trailing 6-month period	—	68.99%	—
Volatility (1Y) Calculated over the trailing 1-year period	—	85.75%	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	—	99.68%	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	—	105.66%	—

Dividends

ATXS vs. CRDF - Dividend Comparison

Neither ATXS nor CRDF has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both ATXS and CRDF in my portfolio?

ATXS and CRDF have a correlation of 0.18, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.